Envoy Medical Inc
COCH
Company Profile
Business description
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Contact
4875 White Bear Parkway
White Bear LakeMN55110
USAT: +1 877 900-3277
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
47
Stocks News & Analysis
stocks
Nvidia earns upgrade as AI buildouts accelerate
Demand for AI infrastructure shows no signs of slowing.
stocks
Weekly earnings wrap: FMG, WDS, COL and more
A closer look at the final major results from August reporting season.
stocks
Chart of the Week: Are US mega-cap stocks undervalued?
Opportunities emerge across US equities.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,243.20 | 84.80 | -0.91% |
| CAC 40 | 8,369.10 | 93.29 | -1.10% |
| DAX 40 | 26,362.14 | 76.18 | 0.29% |
| Dow JONES (US) | 53,463.88 | 113.52 | -0.21% |
| FTSE 100 | 10,827.17 | 50.95 | -0.47% |
| HKSE | 25,565.74 | 87.23 | -0.34% |
| NASDAQ | 26,130.20 | 21.10 | -0.08% |
| Nikkei 225 | 66,131.98 | 130.18 | -0.20% |
| NZX 50 Index | 13,880.05 | 133.16 | -0.95% |
| S&P 500 | 7,675.70 | 1.58 | -0.02% |
| S&P/ASX 200 | 9,038.20 | 78.20 | -0.86% |
| SSE Composite Index | 3,956.57 | 44.05 | 1.13% |